Guardant Health
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
505 Penobscot Dr, Redwood City, Californ...Phone Number
(855) 698-8887Website
www.guardant360cdx.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Guardant Health
Guardant Health, Inc. is a precision oncology company headquartered in Redwood City, California. The company provides a portfolio of liquid and tissue tests, including Guardant360 Liquid CDx and Guardant360 Tissue, to assist healthcare professionals in treatment selection, recurrence risk assessment, and response monitoring across the cancer care continuum. These tests identify actionable biomarkers for advanced solid tumors, including lung, breast, colorectal, and prostate cancers. The company utilizes InfinityAI, a proprietary artificial intelligence and machine learning technology, to integrate genomic, epigenomic, and transcriptomic insights from a large real-world data library to enhance clinical actionability.Explore more
Guardant Health Org Chart
JM
Clinical Laboratory Assistant
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Guardant Health your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Guardant Health is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Guardant Health
Guardant Health, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Guardant Health launches new products
Click to see if Guardant Health had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Guardant Health has new funding data
Check if Guardant Health has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Guardant Health recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Guardant Health as Masked Content
Find more new buyers
Compare Similar Companies to Guardant Health
Compare insights from companies similar to Guardant Health, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Guardant Health is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Guardant Health is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Guardant Health.
Guardant Health Tech Stack
A closer look at the technologies used by Guardant Health
See more technologies
Guardant Health News & Media
Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers The liquid biopsy test is also approved as a companion diagnostic for TAGRISSO® (osimertinib) in...Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers The liquid biopsy test is also approved as a companion diagnostic for TAGRISSO® (osimertinib) in non-small cell lung cancer This is the first blood test to be approved by Singapore's Health Sciences Authority for comprehensive genomic profiling for all solid tumors SINGAPORE, May 30, 2023 /PRNewswire/ -- GuardGuardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced lung and breast cancer
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that UnitedHealthcare (UHC) now covers the Guardant360® CDx liquid biopsy test for patients enrolled in its commercial policies for all FDA-approved companion diagnostic indications. The test is used by oncologists as a companion diagnostic to assess if patients are eligible for a targeted therapy for advanced or metastatic breast or non-small cell lung cancer (NSCLC). TGuardant Health Receives Regulatory Approval for Guardant360 CDx in Japan
Guardant360® CDx is a comprehensive genomic profiling test which utilizes blood samples from patients with advanced solid cancers TOKYO, March 14, 2022 /PRNewswire/ -- The Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Guardant360® CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with advanced solid cancers. The Guardant360 CDx test was also granted approval as a companion diagnostic to iden
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Guardant Health
Sign Up For FreeTo access detailed company insights
Guardant Health, Inc. is a precision oncology company headquartered in Redwood City, California. The company provides a portfolio of liquid and tissue tests, including Guardant360 Liquid CDx and Guardant360 Tissue, to assist healthcare professionals in treatment selection, recurrence risk assessment, and response monitoring across the cancer care c... Read More
